Wird geladen...
PARP inhibition in UV-associated angiosarcoma preclinical models
PURPOSE: Angiosarcoma (AS) is a rare vasoformative sarcoma, with poor overall survival and a high need for novel treatment options. Clinically, AS consists of different subtypes, including AS related to previous UV exposure (UV AS) which could indicate susceptibility to DNA damage repair inhibition....
Gespeichert in:
| Veröffentlicht in: | J Cancer Res Clin Oncol |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer Berlin Heidelberg
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8310857/ https://ncbi.nlm.nih.gov/pubmed/34085099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-021-03678-4 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|